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Substance abuse is a growing problem worldwide, and the negative consequences 
associated with Substance Use Disorder (SUD) impact people across all age groups, but 
the availability of SUD screening tools that show clinical usefulness across generational 
differences is limited. Therefore, more research exploring differences and similarities in 
substance abuse and dependence problems across age groups may provide useful 
information for future research and clinical work. The present study examines age group 
differences in substance abuse and dependence behaviors in three main analyses. 
 First, age differences in abuse and dependence of drug types were examined 
using Chi-square tests for independence with a sample (N = 1,620) who completed 
Structured Clinical Interviews for DSM (SCID) interviews as part of the MIDAS study at 
Rhode Island Hospital. Participants reported on whether they abused different drug types 
(i.e., sedatives/hypnotics/anxiolytics, cannabis, stimulants, opioids, cocaine, and 
hallucinogens) in the past year. Crosstabulations comparing abuse and dependence of 
different drug types across age groups (i.e., ages 18-25, 26-35, 36-49, 50 and older), 
showed that the middle age group (i.e., ages 36-49) reported significantly higher rates of 
past-year substance abuse and dependence compared to the other age groups, for drug 
types including sedative/hypnotics/anxiolytics, cannabis, stimulants, and cocaine. In 
addition, past-year cannabis abuse appeared to be significantly more prevalent across all 
age groups compared to other drug types.  
Second, the factor structure of a proposed substance abuse problems measure, the 
Clinically Useful Substance Abuse Problems Outcome Scale (CUSAPOS), was explored 
with principal components analysis (PCA) and confirmed with confirmatory factor 
 
analysis (CFA) in order to evaluate clinical usefulness in an outpatient psychiatric 
setting. Results from PCAs showed that the proposed CUSAPOS subscales, which assess 
for alcohol and drug abuse problems, should be treated as two distinct scales, the 
Clinically Useful Alcohol Problems Outcomes Scale (CUAPOS) and the Clinically 
Useful Drug Problems Outcome Scale (CUDPOS), each with two factors. Both scales 
show one factor that appears to describe the level of one’s insight regarding their 
substance abuse problems, and the other factor assessing for behavioral consequences of 
substance abuse problems. The factor structure for each scale was confirmed with CFAs 
examining overall goodness of fit. Multigroup CFA was used to test for invariance of 
participant responses to these scales across four Age Cohorts including Young Adults 
(ages 18-25), Adults (ages 26-35), Middle Age (ages 36-49) and Older Adults (ages 50 
and older). Results showed that both the CUAPOS and the CUDPOS are non-invariant, 
suggesting that there may be meaningful differences in the way participants in different 
age cohorts interpreted and responded to the proposed items in each scale.  
Third, after confirming the factor structure of the two distinct scales and 
establishing that they are both non-invariant across Age Cohorts, differences in 
participants mean scores were examined between Age Cohorts for both the CUAPOS and 
the CUDPOS with Analyses of Variance (ANOVAs). Confounding variables that 
potentially influence relationships between age and alcohol or drug abuse, including 
Race, Gender, Mood Impairment, Attention Deficit Hyperactivity Disorder (ADHD), 
Self-Injury, and Childhood Trauma were analyzed using ANCOVAs and two-way 
ANOVAs. ANOVA results showed that the CUAPOS showed no significant differences 
in mean scores between Age Cohorts, however an interaction effect between Age Cohort 
 
and Race showed that the Young Adult, Persons of Color, group reported significantly 
less problems than the rest of the Age Cohort and Race groups, whereas the Middle Age, 
Person of Color group reported significantly more alcohol problems compared to the 
other groups. The CUDPOS showed significant differences in the mean scores between 
the Young Adult group and the Middle Age and Older Adult groups. Gender was found 
to have a significant main effect on CUDPOS scores but showed a nonsignificant 
interaction effect with Age Cohort. Overall, results showed that the only significant 
covariate influencing the relationship between the participant responses on the CUDPOS 
between Age Cohorts was Childhood Trauma. Implications of these findings and study 
limitations are discussed, as well as suggestions for future research further exploring 
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Substance Use Disorder (SUD), described in the DSM 5 as “a maladaptive pattern 
of substance use leading to clinically significant impairment or distress,” is a growing 
concern in the U.S. population. However, little is known regarding appropriate 
assessment and treatment of substance abuse problems across demographic groups, 
particularly in terms of age, race, and gender differences. While valid and reliable 
substance abuse screening tools exist, many are limited in their ability to describe the 
nature and severity of substance abuse problems. The present study examines the 
psychometric properties of a novel substance abuse scale, the Clinically Useful Substance 
Abuse Problems Outcome Scale (CUSAPOS), in order to evaluate clinical usefulness in 
an outpatient psychiatric setting.  
Substance abuse is a growing problem, and the negative consequences associated 
with SUD impact people across all age groups; therefore, understanding more about 
differences and similarities in substance abuse behaviors across age groups, as well as 
patterns within and between age groups in terms of race and gender differences, may 
provide useful information for future research and clinical work. Therefore, an additional 
aim of this study is to examine and describe potential differences in substance abuse 
problems across age cohorts.  
Prevalence and Trends of Substance Abuse and Dependence  
Recent reports from the 2018 National Survey on Drug Use and Health 
(NSDUH), a population-based survey used to assess substance use trends among non-
institutionalized U.S. citizens that are 12-years-old or older, showed that approximately 
20.3 million survey respondents endorsed past-year abuse of alcohol (14.8 million 





year) or an illicit drug (8.1 million people). Past year substance abuse is currently greatest 
for cannabis use (4.4 million people), followed by prescription pain relievers (1.7 million 
people) or heroin (0.5 million people). Although the percentage of people with any SUD 
in 2018 was similar to rates in 2015 to 2017, the percentages of people with alcohol use 
disorder, pain reliever use disorder, or opioid use disorder were lower than in 2015 
(NSDUH, 2018). Lipari, Ahrnsbrak, Pemberton, and Porter (2017), explored the 
implications of perceptions of health risks associated with abuse of different substances 
including cannabis, cocaine, alcohol, and cigarettes across age groups. They found that 
across age groups, individuals who perceive a given substance as having low health risk 
were more likely to develop a SUD with that substance than individuals who perceive the 
substance as having high health risk. One concern highlighted in this report, is that 
although perception of risk was high (four out of five people aged 12 or older) for 
cocaine, heroin, or lysergic acid diethylamide (LSD), the perception of risk for cannabis 
use was significantly lower (i.e., approximately one third of the sample perceived weekly 
cannabis use as causing great risk of harm). This perception of low risk associated with 
weekly cannabis use varied across age groups, with the young adults (ages 18 to 25) 
being the group that reported the lowest perception of risk of harm from weekly cannabis 
use (Lipari et al., 2017).  It is important to note that the data derived from the NSDUH 
does not include data from people with no fixed address (e.g., homeless people not in 
shelters, military personnel on active duty, and institutionalized individuals such as those 
in jails, nursing homes, mental institutions, and long-term care hospitals) (Lipari et al., 
2017). Overall, trends from SUD statistics derived from data from both the United States 





SUD worldwide, alcohol abuse problems have decreased overall (Seitz et al., 2019). 
Problems with abuse and dependence of most substances, including alcohol, cocaine, 
hallucinogens, heroin, and prescription drugs have remained relatively constant over the 
past decade (Lipari et al., 2017; Lipari & Van Horn, 2017; Seitz et al., 2019). However, 
the rates of cannabis abuse continue to increase in the U.S. and in European countries 
(Lipari & Van Horn, 2017; Seitz et al., 2019), as perceptions of the risk of harm from 
cannabis use continue to decrease over time (Lipari et al., 2017). The risks associated 
with the low perception of harm continue to rise the most in youth populations (Lipari et 
al., 2017; Seitz et al., 2019). 
Benefits and Limitations of Commonly Administered SUD Screening Tools 
Although reports continue to indicate a great need for detection and treatment of 
substance abuse problems, few adults are asked about alcohol or drug abuse problems in 
primary health care settings (Pilowsky & Wu, 2012). This is likely since standardized 
diagnostic interviews can take hours to administer and are typically concerned with 
highly specific diagnostic criteria at the expense of sensitivity in detection of problems 
(Carey, 2002). Therefore, the use of psychometrically sound, efficient, screening tools is 
a necessity for the detection of problems in clinical settings, particularly in the context of 
mental health care (Carey, 2002). Brief screening tools are clinically useful given that 
treatment services at many clinical sites are fast paced, with high patient volume in 
relation to the number of clinical staff (Pilowsky & Wu, 2012). These efficient 
assessment tools can be used to quickly detect problems which warrant further 
investigation. Screening tools that are commonly used in busy medical settings, such as 





Test (DAST), the Alcohol Use Disorder Identification Test (AUDIT), Michigan 
Alcoholism Screening Test-Revised (MAST), and CAGE questionnaire, are useful in 
detecting drug or alcohol problems (Hays, Merz, & Nicholas, 1995; Rosenberg et al., 
1998; Reinert 2002; Shields, Howell, Potter, & Weiss, 2007; Skinner, 1982; Yudko, 
Lozhkina, & Fouts, 2007). However, these screening tools have several limitations. For 
example, these measures are limited in that they assess for either drugs (i.e., the DALI 
and DAST) or alcohol (i.e., the AUDIT, MAST, and CAGE), and epidemiological 
evidence suggests that it may be important to assess patients for both alcohol and drug 
problems (Pilowsky & Wu, 2012; Schuckit, 2006). The World Health Organization 
addressed this issue by developing a more comprehensive substance abuse screening tool 
for busy primary care settings, the Alcohol, Smoking, and Substance Involvement 
Screening Test (ASSIST) (Humeniuk et al., 2008). In comparison to similar screening 
tools the ASSIST includes more descriptive items and response options (i.e., scaled 
ratings) inquiring about substance abuse problems experienced within a shorter time 
frame than similar measures (i.e., three months). There is evidence that these features 
greatly improve the sensitivity and specificity in detection of substance abuse problems 
(Humeniuk et al., 2008). Although the ASSIST appears to be an improvement on the 
screening tools discussed above, it can be argued that a three-month time frame is too 
broad for accurate assessment of current problems. This is particularly limiting in the 
context of mental health treatment, given that psychotherapy typically requires more 
current information for weekly treatment planning and tracking of progress. Therefore, a 





potential to significantly improve on the currently available substance use disorder (SUD) 
screening tools. 
Consideration of SUD Age Differences  
While reports show that SUD is a prevalent issue in younger age groups 
(Johnston, O'Malley, Bachman, Schulenberg, & Miech, 2014), trends indicate that there 
is also a growing need for substance abuse interventions in the U.S. old adult population 
(Arndt, Clayton, & Schultz, 2011). Although research findings suggest that drug and 
alcohol abuse is a declining issue in older populations, these results may be misleading. 
For example, while rates of treatment admissions for primary use of alcohol only have 
decreased between 1990 and 2010, rates of primary use of illicit drugs and misuse of 
prescription drugs have increased in older adults (Wu & Blazer, 2011). A comparison of 
age cohorts of persons 50 to 64 years of age and persons 65 years of age and older, 
reveals that the shifting trends in the types of substances abused is related to an 
increasingly high rate of illicit drug use and nonmedical use of prescriptions in the 50 to 
64 years of age cohort (Wu & Blazer, 2011). Lifetime prevalence rates assessed in the 
Monitoring the Future survey appear to coincide with these findings. Eighty-eight percent 
of 50-year-olds reported trying an illicit drug, which is much higher than reports from 
previous 50-year-old cohorts as well as reports from current U.S. adults aged 29 to 30 
(Johnston et al., 2014). This high rate of lifetime prevalence is largely attributed to the 
fact that current 60 to 70-year-olds passed through adolescence near the peak of a U.S. 
drug epidemic (i.e., 1970s-80s) (Johnston et al., 2014). It is also important to note that 
while annual incident rates of substance abuse (i.e., past-year SUD) tend to decline over 





of prescription drugs appears to be increasing the most in women age 50 and older 
(Wastila & Yang, 2006). Given the strong association between substance use problems 
and comorbid mood and anxiety disorders (Compton, Thomas, Stinson, and Grant, 2007; 
Kessler, Chiu, Demler, & Walters, 2005), higher rates of self-reported mood and anxiety 
disorders in older women compared to older men (Byers, Yaffe, Covinsky, Friedman, & 
Bruce, 2010) may be related to the observed increase in substance use problems in older 
women. Overall, the current literature has identified female gender, social isolation, 
depression, and a history of substance abuse as factors that are strongly associated with 
increased risk for misuse and abuse of prescription drugs in geriatric populations 
(Culberson & Ziska, 2008). The generational context, during a time in which current 
“baby-boomers” were adolescents and young adults, is implicated as a key reason for this 
expected shift in substance abuse trends (Johnston et al., 2014). More specifically, in 
comparison to their older counterparts, the “baby-boomer” generation was exposed to the 
U.S. 1970-80s drug epidemic during a developmental period in which they were most 
vulnerable for developing chronic SUD and associated issues throughout adulthood 
(Johnston et al., 2014). A social change that may contribute to the rising concern of SUD 
in older populations is increased prescribing of opioid-based medications, which are 
highly addictive and potentially dangerous pain remedies (Preda, 2015; Simoni-Wastila 
& Yang, 2006).   
Regarding differences in prevalence rates of the types of substances abused across 
age cohorts, abuse of psychostimulants appears to be more prevalent in younger age 
groups (Kaye & Darke, 2012; Kroutil et al., 2005), whereas the association between age 





evidence of an inverse relationship between age and a diagnosis of opioid 
abuse/dependence which indicates that older persons tend to abuse opioids less than 
younger persons (Edlund et al., 2010), more recent evidence shows that opioid abuse and 
associated comorbidities tend to increase exponentially with age (Cicero et al., 2012). 
This suggests that although abuse of opioids may be more prevalent in younger age 
groups, the negative impacts associated with abuse of these agents are much more severe 
in older age groups. In addition, it is oftentimes more difficult to assess substance abuse 
problems in patients who have undergone long-term opioid therapy (Edlund et al., 2010). 
This problem is a particular concern in older persons because, in comparison to younger 
age groups, they are less likely to perceive substance abuse as a problem that requires 
treatment (Wu & Blazer, 2011). This literature highlights the nuanced nature of the 
current state of drug misuse and abuse in the U.S., and the need for future research that 
considers the complexity of individual factors that may contribute to one’s substance 
abuse problems.  
Relationships Between Behavioral Dysfunction and SUD 
It is important to consider the complex mechanisms underlying the relationships 
between SUD and associated risk factors, as it is well established that psychiatric issues 
are prevalent among SUD populations (Kessler et al., 2005). There is some evidence that 
neuroadaptations in stress and reward pathways, as a consequence of the childhood 
behavioral problems (i.e., depression, post-traumatic stress disorder, and ADHD), may 
predispose individuals to abuse substances as they grow into adolescence and adulthood 
(Brady & Sinha, 2005). Childhood events such as sexual and physical trauma as well as 





been implicated as key issues that typically precede and confound the neuroadaptations 
that increase one’s risk for a SUD (Brady & Sinha, 2005).   
It is well established that there are strong relationships between deliberate self-
harm (i.e., intentionally injuring oneself without suicidal intent) and mood disorders such 
as anxiety and depression (Klonsky, Oltmanns, & Turkheimer, 2003). Of note, these 
relationships were found in a sub-clinical, general population. Therefore, these 
associations can be generalized to those outside of the more severe presentations of self-
harm which are typically found in psychiatric populations (Skegg, 2005). Additionally, 
evidence examining relationships between self-harm and SUD indicates that injurious 
behaviors appear to both precede, as well as begin or worsen with abuse of certain 
substances, such as psychostimulants (Muehlmann & Devine, 2008). The underlying 
mechanism associated with the complex interactions between deliberate self-harm and 
SUD appears to be emotional and behavioral dysregulation (Gratz & Tull, 2009). 
Moreover, deliberate self-harm behaviors and comorbid mood disorders (i.e., anxiety and 
depression) appear to be a particularly significant issue in women with childhood sexual 
abuse histories (Gladstone et al., 2004). Mood disturbances appear to have similar 
interactions with SUD, in that mental health disorders can lead to greater risk of 
substance abuse, or conversely, substance abuse can trigger or worsen psychiatric 
symptoms (Brady & Lyniard, 1992; Center for Substance Abuse Treatment, 2005; 
Quello, Brady, & Sonne, 2005; Schuckit, 2006). Overall, the presently discussed risk 
factors play complex, interactive roles in the progression of emotional and behavioral 
problems and associated substance abuse/dependence.  Therefore, relationships between 





childhood trauma, ADHD, and deliberate self-harm) and the proposed CUSAPOS 
subscales will be used to examine convergent and divergent associations in order to 
clarify construct validity. Pearson correlations that indicate positive relationships (i.e., 
convergence) between self-reports on SUD risk factors and the CUSAPOS subscales will 
support the assumption that CUSAPOS items are accurately describing alcohol and drug 








Analytic Plan and Hypotheses 
Exploration of Substance Abuse Problems Across Age Cohorts.  
The initial sample (N = 1620) of outpatient psychiatric patients that completed 
SCID interviews as part of the MIDAS project, were compared based on self-reported 
past-year substance abuse problems. After testing statistical assumptions, analyses 
described substance abuse patterns amongst the different age cohorts. Respective 
substance abuse severity ratings from the SCID interviews were dichotomized in order to 
differentiate between lifetime (i.e., ratings of one or two coded as 0) and past-year (i.e., 
ratings of three and greater coded as 1) substance abuse/dependence. Chi-square (χ2) tests 
will be used to compare the prevalence of past-year substance abuse/dependence of 
respective drug types (i.e., sedative-hypnotic-anxiolytics, cannabis, stimulants, opioids, 
cocaine, and hallucinogens), between different age groups.  
Principal Components Analyses and Confirmatory Measurement Development of 
the CUSAPOS Subscales  
 A subsample of 727 participants who reported past year substance abuse, were 
randomly split into two separate groups in order to be used in principal components 
analysis (PCA) (N = 150) and confirmatory factor analysis (CFA) (N = 577) for 
measurement development of the CUSAPOS subscales. The final factor structure was 
established based on fit indices including the comparative fit index (CFI), Tucker Lewis 
Index, the standardized root mean square residual (SRMR), and the root mean square 
error of approximation (RMSEA). 
A subsample of 624 participants who endorsed at least one substance abuse 





examining variables that may confound the relationships between age and alcohol 
problems, or age and drug problems. ANOVAs assessing mean differences between the 
four Age Cohorts and each of the two CUSAPOS subscales were run before proceeding 
to examining other group differences, based on participant self-report on other measures 
that assess for potential SUD risk factors, as well as demographic characteristics. The 
Age Cohort groups have unequal sample sizes, therefore, the Dunnett C test was used for 
follow-up analyses on significant relationships between Age Cohorts and the CUSAPOS 
subscales. 
To compare alcohol and drug abuse problems amongst different age groups, a 
series of analyses of covariance (ANCOVAs) were run with covariates, including the 
summed total scores of the self-report scales assessing for ADHD (ASRS), Childhood 
Trauma (CTQ), and Self-Injury (SIQ), which may influence the relationships between the 
categorical independent variable, Age Cohort, and continuous DVs, the proposed 
CUSAPOS measure. Two-way ANOVAs were conducted to examine the potential effect 
that confounding variables, including Race, Gender, and Mood Impairment may have on 
the mean differences in scores on each respective scale between Age Cohorts.  
Hypothesis I 
It is predicted that the descriptive crosstabulations will show significant group 
Chi-square differences in the types of drugs participants reported abusing in the past year 
(N =1,620) between Age Cohorts. Based on previous literature, it is expected that older 
age groups (i.e., Middle Age and Older Adults) will struggle with substances that may 
partially reflect problems with prescription drug abuse, such as 






 The internal consistency of items is expected to be adequate in both of the 
CUSAPOS subscales. A series of PCAs will detect any items that appear redundant and 
should therefore be eliminated from the measure. The two respective CUSAPOS subscale 
scores will be significantly correlated with scores on the measures that assess SUD risk 
factors, including those that assess for Childhood Trauma (CTQ), Self-Injury (SIQ), and 
ADHD symptoms (ASRS). Examination of factor structure is expected to show evidence 
for two distinct subscales that assess for alcohol and drug abuse problems, respectively.  
Hypothesis III 
 It is expected that mean scores on the respective CUSAPOS subscales will vary 
significantly between age groups, specifically between younger and older age cohorts 
(i.e., Young Adult and Adult groups compared to Middle Age and Older Adults groups), 
due to generational differences. In addition, given that previous research indicates that 
factors such as race, gender, mental health problems, childhood trauma, ADHD, and Self-
Injury may influence the severity of SUD problems across age groups, it is expected that 
the present study’s ANCOVAs and two-way ANOVAs will reveal the influence that 
confounding variables including Race, Gender, Mood Impairment, ADHD, Childhood 
Trauma, and Self-Injury, may have on the mean differences in the respective CUSAPOS 
subscale scores, between Age Cohorts. However, as discussed above, the anticipated 






Participants and Procedures  
The present study utilized cross-sectional data from an ongoing study, Methods to 
Improve Diagnostic Assessment and Services (MIDAS) at Rhode Island Hospital (PI: 
Mark Zimmerman, MD). Data were gathered from psychiatric outpatients seeking 
treatment at the Outpatient Psychiatry Practice of Rhode Island Hospital (RIH) 
(Dalrymple et al., 2013). Participants were excluded from the MIDAS study if they had 
difficulties communicating in the English language or had a history of developmental 
disabilities (Zimmerman et al., 2014).  Of note, all participants were insured (i.e., not on 
Medicaid) and mental health treatment seeking. Participants underwent a clinician-
administered Structured Clinical Interview for DSM Disorders (SCID), which provides 
supplemental details of participants’ presentation of symptoms (Zimmerman, Morgan, 
Dalrymple, Young, and Chelminski, 2014). Trained SCID diagnostic interviewers rated 
patients’ SUD severity upon intake, with single-item severity ratings ranging from 1 
(least severe) to 8 (most severe) for respective drug classes including sedative-hypnotic-
anxiolytics, cannabis, stimulants, opioids, cocaine, and hallucinogens. Participants (N = 
1,620) who reported abusing substances at some point in their lifetime were included in 
the sample used to evaluate the prevalence of SUD by different age groups. For the 
purpose of these exploratory analyses, participant ratings were dichotomized to 
differentiate between lifetime and past-year substance abuse/dependence. Data assessing 
mood disorders and the severity of mood impairment were also derived from participants’ 
responses on the SCID.  
In addition to these interviews, participants were also asked to complete a self-





factors discussed above as well as the CUSAPOS subscales. Of the MIDAS study 
participants who completed the CUSAPOS items, only 727 participants that reported any 
alcohol or drug problems are included in the PCAs (N = 150) and CFAs (N = 577) of the 
CUAPOS and the CUDPOS. Demographics were assessed with single item measures. 
The demographic items of interest for the present analyses include age (i.e., age groups of 
18-25, 26-35, 36-49, 50 and older), gender (i.e., female or male), and race/ethnicity (i.e., 
White, Black, Hispanic, Asian, Portuguese, Other, Native Hawaiian/ Other Pacific 
Islander, American Indian/Alaskan Native). The participants’ ages range from 18 to 84-
years-old. Approximately 25% are aged 18 to 25, 20% are aged 26 to 34, 33% are aged 
35 to 49, 22% are aged 50 and older. The prevalence of females (53%) in this sample is 
similar to males (47%). In terms of race/ethnicity, the majority of the sample is White 
(88%), with Black being the second most prevalent racial group (4.8%). A small portion 
of the sample reported Hispanic (2.3%), Asian (1.4%), or Portuguese (2.2%) 
races/ethnicities.  
Data from the age variable were recoded using SPSS version 26 software (IBM 
Corp, 2019), and grouped into four distinct age categories: Young Adult (coded as 0), 
Adult (coded as 1), Middle Age (coded as 2), and Old Adult (coded as 3). The Race 
variable was also recoded due to an inadequate sample size (N < 50) for the present 
analyses in the Black (N = 33), Hispanic (N = 14), Asian (N = 10), Portuguese (N = 14), 
and Other (N=5) racial groups, with no participants endorsing the Native Hawaiian/ Other 
Pacific Islander, or American Indian/Alaskan Native categories. These race groups were 
recategorized into two groups labeled as ‘Persons of Color’ (N =76) and ‘White’            






Substance Abuse Problems and Severity Measures  
Clinically Useful Substance Abuse Problems Outcomes Scales (CUSAPOS) 
The proposed screening tool, CUSAPOS, was derived mainly from the DSM-IV 
and two 15-item potential subscales were developed to better understand the severity of 
problems associated with alcohol and drug abuse, respectively. Of note, these two item 
sets cannot be considered as respective alcohol and drug abuse subscales until analyses 
for measurement development, as described below, confirm the validity and factor 
structure of the total 15 items in each scale. The items are self-administered and the 
instructions prompt participants to reflect on substance abuse problems experienced 
within the past two weeks. Items are rated on a 5-point Likert scale, ranging from 0 (‘Not 
at all true’) to 4 (‘Almost always true’). Higher ratings, which are derived from the total 
score for each subscale, indicate more problems with abuse of alcohol and drugs, 
respectively.  
Substance Abuse Severity Ratings 
The Structured Clinical Interview for DSM-IV Disorders (SCID) is an extensive 
diagnostic tool that has shown reliability and validity across many different groups (First, 
Spitzer, Gibbon, & Williams, 2012). The severity of substance abuse behaviors across 
respective classes of drugs including sedative-hypnotic-anxiolytics, cannabis, stimulants, 
opioids, cocaine, and hallucinogens is measured with one-item ratings within the SCID. 
These items were clinician-administered, and participants were asked to clarify the 
specific substance(s) they struggle with and rate their self-perceived severity of abuse of 
respective substances on an 8-point Likert scale, with higher ratings indicating greater 





most clinically significant indicators for life-long sobriety, significantly improved 
cognitive functioning, and improved overall satisfaction with life (Hagan et al., 2017), 
ratings were dichotomized to differentiate participants between two groups: lifetime 
substance abuse/dependence, and past-year substance abuse/dependence.   
SUD Risk Factor Assessments 
Mood Impairment 
The Mood Disorders and Anxiety Disorders subscales of the Structured Clinical 
Interview for DSM Disorders (SCID) were used to assess for depression and anxiety 
symptoms. Trained interviewers rated each symptom based on patient responses on a 3-
point scale with 1 indicating ‘absent or false’, 2 indicating ‘subthreshold’, and 3 
indicating ‘threshold or true.’ Some sections include additional ratings: 4 which indicates 
the symptom ‘may be better accounted for by a general medical condition (GMC),’ 5 
indicates the symptom is ‘definitely better accounted for by a GMC,’ and 6 indicates 
‘baseline.’ SCID raters indicated that the patient reported inadequate information for 
appropriate rating of an item with ‘?’.  Although the SCID that was utilized in this study 
is based on DSM-IV classification of disorders, interpretations were modified for the 
present study in order to reflect any DSM-5 revisions (Zimmerman et al., 2014). 
Interviewers used the SCID to assess whether participants meet criteria for several 
different mood disorders, and they also assessed the level of mood impairment with 
scores summed into a categorical variable that indicates whether the participant meets 
criteria for severe mood impairment (coded as 1) or do not meet criteria for severe mood 
impairment (coded as 0). The present study is interested in examining the cognitive and 





instead of using the variable that indicates whether participants meet criteria for a given 
DSM-IV disorder, the Mood Impairment variable was evaluated as a categorical 
independent variable (IV) in the present study.  
 Adult ADHD Self-Report Scale (ASRS), Symptom Checklist 
 The ASRS, Symptom Checklist (Kessler et al., 2005), is a self-report measure 
that includes 18 items describing problems caused by inattentive and hyperactive 
symptoms associated with ADHD (e.g., “How often do you interrupt others when they 
are busy?”). Participants reported the severity of these problems, within the past six 
months, by endorsing ratings ranging from ‘Never’ to ‘Very Often.’ A sum of the total 
item responses was used to indicate the severity of interfering symptoms caused by 
ADHD. Psychometric evaluation of this measure revealed it is useful in assessing for 
ADHD in SUD populations (Daigre et al., 2009). Participants’ summed scores on the 
ASRS were used to examine the effect ADHD symptoms may have on the relationships 
between age and alcohol or drug abuse problems. Appendix A shows the full list of 
ASRS items and ratings. 
Childhood Trauma Questionnaire (CTQ) 
The CTQ is a self-report measure that includes 53 items that inquire about sexual 
and physical abuse and neglect, family relationships/emotional support, and parenting 
behaviors (Bernstein, Fink, Handelsman, & Foote, 1994). Items reflect scenarios that 
describe both abusive and healthy family relationships, and the items that reflect 
protective factors were reverse scored (e.g., “There was someone in my family whom I 
admired and wanted to be like”). Participants are asked to rate each item on a 5-point 





summed scores indicate greater severity of childhood trauma (Gaudiano & Zimmerman, 
2010).  Participants’ summed scores on the CTQ were used to examine the effect a 
history of childhood trauma may have on the relationships between age and alcohol or 
drug abuse problems. Appendix B shows the complete list of CTQ items and ratings. 
Self-Injury Questionnaire (SIQ) 
The SIQ is a 13-item, self-report measure, that assesses whether an individual had 
deliberately injured him/herself by cutting, burning, picking, hitting, or scratching 
themselves in the past three months. Items were derived from the Inventory of Statements 
About Self-Injury (ISAS), which assesses for 13 functions of non-suicidal self-injury 
(Klonsky & Glenn, 2009). Participants reported how often they engaged in these 
behaviors, within the past three months, on a 4-point scale, from 0 ‘Never,’ to 3 ‘Three or 
more times.’ Higher scores indicate greater severity of deliberate self-harm behaviors. 
Total scores showing more severe deliberate self-harm behaviors typically indicate higher 
risk for other forms of behavioral dysregulation as well as suicidal thoughts and 
behaviors (Santa Mina et al., 2006). Appendix C shows the complete list of SIQ items 







Substance Abuse Across Age Groups 
In order to describe the rates of abuse and dependence of different classes of 
drugs (i.e., sedatives/hypnotics/anxiolytics, cannabis, stimulants, opioids, cocaine, and 
hallucinogens) amongst different age cohorts (i.e., 18-25, 26-35, 36-49 and 50+ years-
old), crosstabulations were conducted on a sample of participants who endorsed having 
abused substances at some point in their lifetime (N = 1,620). Substance abuse and 
dependence severity ratings, ranging from 1 (least severe) to 8 (most severe) were 
assessed by an interviewer who was trained in administration and scoring of the 
Structured Clinical Interview for DSM IV Disorders (SCID). For the purpose of the 
present analyses, ratings were dichotomized to differentiate between lifetime (N = 893) 
and past-year substance abuse/dependence (N = 727).  
Chi-square tests for independence were used to examine age group differences in 
drugs abused in the past year. Results revealed significant associations between age and 
sedative/hypnotics/anxiolytics, χ2 (3, N = 1620) = 19.85, p <.001, cannabis, χ2 (3, N = 
1620) = 23.85, p < .001, stimulants, χ2 (3, N = 1620) = 36.03, p <.001; and cocaine use in 
the past year, χ2 (3, N = 1620) = 32.37, p < .001. No significant age differences were 
found in opioid abuse and dependence, χ2 (3, N = 1620) = 1.26, p = .74, and 
hallucinogens, χ2 (3, N = 1620) = 3.22, p = .36, and follow-up analyses revealed similar 
severity ratings across Age Cohorts. Cannabis abuse was the most prevalent across all the 
age groups (Young Adult = 21.2%, Adult = 23.5%, Middle Age = 30.5%, and Old Adults 
= 13.5, compared to all other substances included in the analyses. Overall, the 36-49 





(6.5%), cannabis (30.4%), stimulants (7.3%), opioids (6.1%) and cocaine (13.1%) 
compared to the other age groups. Table 1 presents detailed information on the rates of 
past year abuse of different drug types, within four age groups (i.e., ages 18 to 25, ages 
26 to 35, ages 36 to 49, and ages 50 and older). 
Principal Components Analyses Results  
To examine the factor structure of the proposed CUSAPOS measure, the 30 item 
responses were factor analyzed using PCA with promax (oblique) rotation, using SPSS 
software version 26 (IBM corp., 2019) on a subsample that was extracted from the total 
727 participants (N = 150). Table 2 shows demographic information, including gender 
and race, by Age Cohort, from the 727 participants included in the measurement 
development analyses. Table 3 shows the demographic information for the subsample 
used for the PCAs, exploring the factor structure of the initial proposed 30 items. 
 It was hypothesized that the 30-item response set in the proposed CUSAPOS 
would show a two-factor structure for alcohol and drug problems, respectively; however, 
PCA results showed that less than half of the variance that can be explained by a two-
factor structure for alcohol (35.92%) or drug problems (23.57%). In addition, results from 
PCAs exploring the initial factor structure of the complete set of 30 proposed items 
revealed that items loaded onto two distinct factors, with the first 15-item set appearing to 
assessing for alcohol problems, and the latter 15 for drug problems. Table 4 shows the 30 
items and their factor loadings from the exploratory PCA results. The KMO result 
assessing the overall fit of the total 30 items (.882) shows slightly weaker fit than the 
respective Clinically Useful Alcohol Problems Scale (CUAPOS) (.991) and the Clinically 





showing a significant chi-square test result, which indicates good overall fit for each scale 
(Krishnan, 2010). Overall, these results suggest that the items should be separated into 
two respective scales, separately assessing for alcohol and drug problems. To better 
understand the factor structure of each scale, two separate PCAs with a Promax (oblique) 
rotation, and two fixed factors, were conducted with the item response sets from each 
respective scale.  
CUAPOS Development  
The initial PCA results for the 15 items assessing for alcohol abuse problems show a two-
factor structure with Factor 1 explaining 51.91% of the total variance. Upon further 
examination of the items in the CUAPOS, it appears that the items loading on Factor 1 
assess for self-awareness or insight regarding alcohol problems (e.g., I thought that my 
drinking was a problem), whereas items loading on Factor 2 assess for alcohol abuse 
behaviors (e.g., I had more than 3 drinks of alcohol in a day). A correlation matrix was 
used to identify items that highly correlate (i.e., redundant items) in each respective scale. 
Items that highly correlated with multiple items were deleted. In addition to identifying 
correlated items for item reduction, weaker loadings (i.e., ≥ .40) and cross-loadings were 
used as an indicator to extract additional items, including item 71 (i.e., “I couldn’t stop 
drinking when I wanted to”). After several iterations of item response sets were analyzed, 
PCA results showed that the best fit for the CUAPOS is a two-factor model with a total 
of nine items. After identifying the factor structure of this scale, the goodness of fit of this 








The 15 items assessing for drug abuse problems were also factor analyzed using PCA 
with a Promax (oblique) rotation. Consistent with the CUAPOS factor structure, Factor 1 
in the CUDPOS appears to describe insight on one’s own drug abuse problems and it 
explains 65.79% of the total variance, whereas Factor 2 appears to assess for the 
behavioral problems associated with drug abuse and dependence. Highly correlated 
items, and items with low factor loadings or cross-loadings, were evaluated for the 
extraction of complicated items such as item 87 (i.e., “I had a strong urge to use drugs”) 
in the CUDPOS scale. The PCA results exploring different iterations of item response 
sets, indicated that the best fit for the CUDPOS is a two-factor model with a total of eight 
items. This factor structure was confirmed with CFAs examining the overall model fit, as 
discussed below. Table 5 shows the mean (M) and standard deviation (SD), as well as the 
factor loading for each item included in the confirmed factor structure for both the 
CUAPOS and the CUDPOS.  
Confirmatory Factor Analysis Results 
The statistics program, R, was used to perform CFAs on the remaining 577 
participants, to evaluate the goodness of fit of each model (i.e., the CUAPOS and the 
CUDPOS) across four different age cohorts: Young Adults (N = 152), Adults (N = 132), 
Middle Age (N = 201), and Old Adults (N = 139). Before running CFAs on the CUAPOS 
and the CUDAPS, respectively, exploratory analyses confirmed that statistical 
assumptions such as normality, linearity, and homoscedasticity were met for the 
distribution of scores across age cohorts, for both scales. In addition, the large size of the 





Chi-square tests are not a reliable indicator for the present analyses, given that the large 
sample size creates a significant chi-square result, artificially rejecting the model (Fischer 
& Karl, 2019). Therefore, each two-factor model was evaluated for goodness of fit based 
on four alternative fit indices including the CFI, TLI, SRMR, and the RMSEA (Cook, 
Kallen, & Amtmann, 2009; Xia & Yang, 2018). A CFI and TLI value of .95 or higher 
indicates good model fit, and in contrast, lower values (ideally between .06 to .08) for the 
lack of fit indices, RMSEA and SRMR, indicate better model fit (Fischer & Karl, 2019). 
The two-factor solution for the CUAPOS showed good model fit across indices (CFI = 
.997, TLI = .995, SRMR = .046, RMSEA = .064), as well as the CUDPOS (CFI = 0.972, 
TLI = .958, SRMR = 0.031, RMSEA = 0.081). Both the CUAPOS and CUDPOS showed 
good fit for each respective age cohort. Table 6 shows detailed information on the 
goodness of fit indices by age cohort, for both the CUAPOS and the CUDPOS. 
Multigroup Confirmatory Factor Analyses for the CUAPOS 
To examine whether the CUAPOS has the same measurement properties across 
the four age cohorts (i.e., Young Adults, Adults, Middle Age, and Old Adults) multi-
group CFA was the statistical method employed. In a hierarchical fashion, CFAs were 
performed with different levels of parameter constraints, in order to test the level of 
invariance across age cohorts (Fischer & Karl, 2019) For the first step, a CFA analyzed 
form invariance, or configural invariance to examine the overall fit, with the theoretical 
assumption that the items were loaded on the same latent factor with no parameter 
constraints, in the CUAPOS. The fit indices for the configural invariance of the CUAPOS 
show results that are below the typical cut-off levels for good model fit across all indices 





adequate model fit when the large total sample size (N = 577) is considered (e.g., CFI ≥ 
.901, Shi et al. 2019). The second level to invariance testing is factorial, or metric 
invariance, which constrains factor loadings to be equal across age groups. This test 
reveals any non-uniform item bias amongst the different age cohorts (Fischer & Karl, 
2019). Compared to the configural invariance results, metric invariance results show 
poorer model fit across indices (CFI = .898, TLI = .883, SRMR= .088, RMSEA = .127). 
Given the relatively poor fit of the model at the metric invariance level, invariance testing 
did not proceed to comparisons of models with more parameter constraints. An Analyses 
of Variance (ANOVA) compared the chi-square test statistics between the first, 
configural model, and the second, factorial model: !2 (21) 66.86, p = .001. A significant 
chi-square difference test result (p ≥ .05) would indicate that responses on the CUAPOS 
are theoretically equivalent across age groups, meaning that the scale items assess for the 
same latent constructs, in a similar manner across age cohorts (Fischer & Karl, 2019). 
Therefore, the significant chi-square difference test result between the two models (i.e., 
configural invariance and metric invariance) for the CUAPOS, indicates that the model 
does not show adequate invariance to assume that the scale items equivalently assess for 






Multigroup Confirmatory Factor Analysis for the CUDAPS  
A series of CFAs were performed to assess the level of invariance with different 
parameter constraints. With no parameter constraints, the CFI and the SRMR indicate 
adequate goodness of fit for the configural invariance model (CFI = .913, TLI = .872, 
SRMR = .05, RMSEA = .153). As previously mentioned, the lower than desired TLI 
statistic as well the higher than desired RMSEA, may be influenced by the large total 
sample size (Shi et al., 2019). The second step, a CFA constraining the factor loadings to 
be equal for metric invariance testing, showed adequate fit across all indices (CFI = .90, 
TLI =.881, SRMR = .094, RMSEA = .148). Therefore, like the CUAPOS, invariance 
testing did not continue to show good model fit with added constraints (i.e., scalar 
Invariance, and strict invariance). An ANOVA compared the CFA results between the 
first (configural invariance) and second (metric invariance) models and showed a 
significant chi-square difference test result. This indicates that the CUDPOS is non-
invariant amongst age cohorts, and it cannot be assumed that the items reflect the same 
latent factors similarly across age groups. Table 7 shows results from the invariance 
testing on both the CUAPOS and the CUDPOS. 
Descriptive Statistics for Demographic Characteristics and SUD Risk Factors 
In order to reduce skew in participants’ responses to items on the CUAPOS and 
the CUDPOS, the cases that did not endorse any substance abuse problems (i.e., 
participants who reported a total score of zero on both scales) were eliminated. Only the 
participants who endorsed at least one substance abuse problem on either the CUAPOS 
or the CUDPOS were included in the analysis of variables that may confound the mean 





Correlations were used to describe the linear relationships between the scales used 
in the present study, which include the CUAPOS (N = 624, M = 6.63, SD =7.40), the 
CUDPOS (N = 624, M = 3.2404, SD = 6.15), the ASRS (N = 326, M = 35.39, SD = 
12.67) the SIQ (N = 515, M = 2.04, SD = 3.56) and the CTQ (N = 544, M = 106.78, SD = 
45.88), on the subsample of participants who endorsed at least one substance abuse 
problem on either the CUAPOS and the CUDPOS. Table 8 shows the descriptive 
statistics for each scale and the correlations of mean scores between the scales across the 
four age groups (Young Adults, Adults, Middle Age, and Older Adults). A weak, yet 
statistically significant positive correlation was found between the CUDPOS and the SIQ 
(r (515) = .09, p < .05), meaning that as self-reported problems related to drug abuse 
problems increase, self-injurious behaviors may be likely to increase as well. The ASRS 
showed a significant positive correlation with the CUDPOS (r (326) = .15, p < .01), 
meaning that as participants reported more ADHD symptoms, they also reported more 
drug abuse problems. The CUDPOS also showed a weak, but significant inverse 
relationship with the CTQ (r (515) = -.09, p < .05), which indicates that as participants 
reported less childhood trauma, they also reported less drug abuse. The SIQ also showed 
a positive correlation to the ASRS (r (326) = .26, p < .01), indicating that higher levels of 
ADHD symptoms may be related to more severe levels of self-injury. Of note, the 
CUAPOS and the CUDPOS were orthogonal, with a correlation close to a zero (r (624) = 
.02, p > .05). This result is consistent with the PCA results previously described, which 
suggest that the proposed CUSAPOS measure should be treated as two conceptually 






Demographic Characteristics on Participants Who Self-Reported Substance Abuse 
Problems in the Past Week 
To describe the categorical groups examined in the present analyses, 
crosstabulations compared gender, race, and mood impairment by Age Cohort, in a 
subsample of participants who reported experiencing at least one substance abuse 
problem in the past week.  Results show that percentages for female (51.6%) and for men 
(48.4%) were similar to the larger sample of 727 of participants who reported having 
abused a substance in the past year; however, the larger sample shows more of a 
percentage difference between females (53.0%) and males (47.0%). Similar to the larger 
sample of 727, the smaller sample of past week substance abusers have a similar 
percentage of White participants (87.8%), with only 4.8 percent representing Persons of 
Color. Table 9 shows a detailed description of this subsample’s demographic 
characteristics, as well as the significant mood impairment, by Age Cohort.  
After the best fitting models for both the CUAPOS and the CUDPOS were found 
using CFAs (N = 577), the sample used for CFAs was merged with the sample used for 
the initial PCAs (N = 150), to return to the total number of participants in the present 
study (N = 727). A subsample that includes the data from the CUAPOS and the CUDPOS 
together with data derived from continuous and dichotomous measures that assess several 
substance abuse risk factors as well as demographic characteristics including: Gender 
(i.e., Female or Male), Race (i.e., White or Person of Color), the Adult ADHD Self-report 
Scale, Symptom Checklist (ASRS), the Self-Injury Questionnaire (SIQ), the Childhood 
Trauma Questionnaire (CTQ), and Mood Impairment (i.e., rated as ‘yes’ or ‘no’ using 
SCID criteria for impairment and distress). Ratings from these measures will be used to 





between participants’ age and their responses on the CUAPOS and the CUDPOS, 
respectively. As previously described, of the total 727 participants, those who denied all 
the items on the two respective scales (i.e., cases who reported a total score of zero on 
both the CUAPOS and CUDPOS) were eliminated from the dataset, resulting in a sample 
size of (N = 624). Although deleting cases with zero totals on the two combined scales 
addressed some of the non-normality of the distribution of scale scores, follow up 
exploratory analyses revealed that the data was highly skewed, with several outliers in 
each respective scale. Log transformation was used in SPSS version 26 (IBM corp., 
2019), which corrects normality of the distribution of scores across Age Cohorts. 
Exploratory analyses confirmed the statistical assumptions for Analysis of Variance 
(ANOVA), including normality and homogeneity of variance, were met before the two-
way (ANOVA) and Analysis of Covariance (ANCOVA) were used to examine possible 
relationships between SUD risk factors and relationships between age cohort and scores 
on each respective scale. 
Comparisons of Age Cohort Differences on the CUAPOS  
A one-way ANOVA comparing mean differences of participant scores on the 
CUAPOS between the four different Age Cohorts (i.e., Young Adults, Adults, Middle-
age, and Old Adults) showed nonsignificant results (F (3, 620) = .368, p = .776). This 
indicates that there are no significant age group differences in participants’ responses to 
the CUAPOS items. Although results indicated no main effect between the independent 
variable (IV), Age Cohort, and the dependent variable (DV), participant responses on the 
CUAPOS, a series of two-way ANOVAs were conducted to evaluate the relationship 





demographics and risk factors for substance abuse problems including, Race (White or 
Persons of Color), Gender (Female or Male), ADHD (total score on the Adult ADHD 
Self Report scale Symptom Checklist), Mood Impairment (Yes or No), Self-injury (total 
score on the SIQ), and Childhood Trauma (total score on the CTQ).   
Although the initial ANOVA examining Age Cohort differences on mean scores 
on the CUAPOS was non-significant, follow up analyses controlling for confounding 
variables were conducted. Two-way ANOVA was the statistical method used to examine 
the mean changes in the relationship between Age Cohort and participant scores on the 
CUAPOS when categorical variables including Race, Gender and Mood Impairment 
were controlled for. Results showed nonsignificant interactions in mean differences on 
Alcohol Abuse Problems scores between Age Cohorts and Gender (F (3, 616) = 1.284, p 
= .279), as well as Age Cohorts and Mood Impairment (F (3, 616) = .899, p = .441). 
An interaction between Age Cohort and Race and scores on the CUAPOS showed 
statistical significance (F (3, 616) = 2.802, p = .039). Participants in the Person of Color 
group who were in younger age cohorts (i.e., Young Adult and Adult), as well as the Old 
Adult group, reported significantly less alcohol abuse problems than compared to the 
Middle Age, Person of Color group. This group also scored significantly higher than the 
White groups across Age Cohorts. Conversely, participants in Young Adult, Persons of 
Color subgroup, reported significantly less alcohol abuse problems compared to all the 
Age Cohorts in the White, sample as well as the three older Age Cohorts in the Persons 
of Color group. Participants in the Age Cohorts, Adult and Old Adult, scored similarly on 
the CUAPOS across race groups. Figure 1 is a line graph illustrating the significant 





The two-way ANOVA results also showed non-significant main effects between 
the two IVs, Age Cohort (F (3,616) = 2.551, p = .055) and Race (F (1,616) = .088, p = 
.766) and the DV (i.e., scores on the CUAPOS). Separate, follow up ANOVAs 
examining the main effect of CUAPOS scores across the different Age Cohorts (F (3, 
620) = .368, p = .776), as well as the main effect of CUAPOS scores across the Race 
groups (F (1, 622) = .004, p = .947), yielded non-significant results. This suggests that 
participants’ CUAPOS scores do not significantly differ between the four different Age 
Cohorts. Therefore, the two IVs, Race and Age Cohort, show a significant interaction 
effect on Alcohol Abuse Problems (DV), a finding not evident when race and age cohort 
are not in the two-way ANOVA model together. It is important to note that this result 
may be difficult to accurately interpret due to unequal sample sizes in each group with 
the large majority being White (N = 548). In addition, this variable is limited in it’s 
ability to provide descriptive information on race, given that the sample sizes of 
individual race groups were too small for the present analyses.  
A series of ANCOVAs showed nonsignificant results for the influence of 
participant responses on the SIQ (F (3, 515) = .181, p =.909), the ASRS (F (3, 321) = 
.328, p = .805), and the CTQ (F (3, 539) = .357, p = .784).  
Comparisons of Age Cohort Differences on the CUDPOS 
A one-way ANOVA comparing mean differences of participant responses on the scale 
between the four different age cohorts (i.e., Young Adults, Adults, Middle-age, and Old 
Adults) showed significant group differences (F (3, 620) = 3.728, p = .011). A follow up 
Dunnett C test identified significant mean differences in responses to the CUDPOS 





the Old Adult (M = .377, SD = .122, p = .014) groups. Table 10 describes results from 
ANOVAs assessing mean differences in scores on both the CUAPOS and the CUDPOS, 
by Age Cohort.  
 A series of two-way ANOVAs were conducted to examine the influence 
categorical IVs including Race (White or Persons of Color), Gender (Female or Male), 
Mood Impairment (Yes or No) the mean differences in CUDPOS scores between Age 
Cohorts. Results showed nonsignificant interactions in mean differences on CUDPOS 
scores between Age Cohort and Gender (F (3, 616) = 2.489, p = .059), Age Cohort and 
Race (F (3, 616) = .899, p = .441) and Age Cohort and Mood Impairment (F (3, 616) = 
.349, p = .790). However, a significant main effect was found for the mean differences 
between Female and Male responses on the CUDPOS (F (1, 616) = 7.526, p = .006). A 
follow up one-way ANOVA was conducted to further assess the significant main effect 
between Gender and participants’ scores on the CUDPOS (F (1, 622) = 5.446, p = .020). 
These findings indicate that Age Cohort and Gender separately show main effects on 
responses on the CUDPOS; however, when the interaction between Age and Gender is 
considered in relation to mean differences in scores on the CUDPOS, the interaction 
effect between the two IVs and the DV loses statistical significance (p = .059). Table 11 
shows detailed results from the two-way ANOVA analyzing the mean differences in 
CUDPOS scores across Gender and Age Cohort groups. 
A series of ANCOVAs were conducted to compare mean group differences in 
participant responses on the CUDPOS between Age Cohorts, while controlling for 
covariates including Self-injury (total score on the SIQ), ADHD (total score on the 





the mean difference between CUDPOS scores by Age Cohort, was found to be non-
significant (F (3, 510) = 1.815, p = .143); however, the SIQ was found to be significantly 
related to the CUDPOS (F (1, 510) = 5.793, p = .016). Results also showed that ADHD 
was not found to significantly influence the mean differences between Age Cohort group 
scores on the CUDPOS (F (3, 321) = .748, p = .524). Overall, results show that 
Childhood Trauma was the only significant covariate, moderating the mean differences in 
CUDPOS scores between Age Cohort groups (F (3,539) = 2.848, p = .037). Further, the 
CTQ and CUDPOS participant responses do not significantly relate to each other (F (1, 
539) = 1.183, p = .277). These results show that Childhood Trauma does not directly 
influence the DV, the CUDPOS, but it is a significant covariate that impacts the mean 
differences between Age Cohorts and responses on the CUDPOS. Table 12 shows 
detailed results for the significant influence childhood trauma appears to have on the 







 The first goal of this study was to evaluate the psychometric properties of a 
proposed scale to provide a clinically useful index of substance problems with 
differentiation between alcohol and other substances.  It was hypothesized that 
generational differences in alcohol and substance problems would be found and that these 
generational differences would be influence by other factors such as presence of 
depression, anxiety, or ADHD history.  The generational effects were assessed by 
examined group comparisons in self-reported substance abuse and dependence problems, 
across four different age groups, including Young Adult, Adult, Middle Age, and Older 
Adult. As part of the MIDAS study at Rhode Island Hospital, participants reported 
whether they experienced past year substance abuse in a SCID interview and SUD 
problems were assessed by participants’ responses on two distinct scales in the Clinically 
Useful Substance Abuse Problems Outcomes Scale, the CUAPOS and the CUDPOS. The 
total sample (N = 1,620) represents psychiatric outpatients who disclosed past-year 
substance abuse history in a SCID interview as part of the MIDAS study. Of the larger 
sample of 1,620, 727 reporting past-year substance abuse and dependence, and 624 
reporting at least one alcohol or drug related problem in the past week.   
For the first study goal a series of exploratory, confirmatory, and metric 
invariance analyses were used to examine the factor structure of the proposed CUSAPOS 
measure. This graded set of analyses found that the items of the CUSAPOS were not best 
characterized as one scale with two factors that assess substance and alcohol use.  
Instead, measure development analyses suggested that the 15 items each assessing 





conducted separately on each of the 15-item drug and alcohol item sets supported a two-
factor structure for each independent scale (name the two factors).  Confirmatory 
analyses supported the two-factor structure of each new scale; the Clinical Useful 
Alcohol Problems Outcomes Scale (CUAPOS) and the Clinically Useful Drug Problems 
Outcomes Scale (CUDPOS). However, these new scales were not found to be invariant 
by age grouping suggesting that the interpretation of the items for each scale varied from 
one age group to another. Multigroup CFAs confirmed good model fit across Age 
Cohorts for both the CUAPOS and the CUDPOS. Two-way ANOVAs and ANCOVAs 
were used to examine the influence confounding variables that represent demographic 
characteristics (i.e., Race, Gender), as well as SUD risk factors (i.e., Mood Impairment, 
ADHD, Childhood Trauma, and Self-Injury), which may influence the mean differences 
in participants responses to the respective CUSAPOS subscales, between the four Age 
Cohorts. 
Analyses comparing drug abuse problems (i.e., drug categories: 
sedatives/hypnotics/anxiolytics, cannabis, stimulants, opioids, cocaine, and 
hallucinogens) across the four age cohorts (i.e., Young Adults, Adults, Middle Age, and 
Old Adults) revealed that cannabis was overwhelmingly the most common substance 
abused across age groups. This finding is consistent with national and global reports 
indicating that the perception of harm from cannabis use is decreasing overtime, and 
consequently, the rates of cannabis abuse continue to increase over the time. This appears 
to be a growing problem in all age groups. Descriptive results also showed that compared 
to other Age Cohorts, the Middle Age group showed the highest rates of substance abuse 





2016 National Survey on Drug Use and Health (NSDUH) showing a growing concern of 
increasing rates of SUD problems in middle age and old adult populations (Perlman, 
2019). In fact, Han and Palamar (2018) examined trends of marijuana use in middle-aged 
and older Americans found that the percentage of respondents age 50 to 64 (9%) and the 
percentage of respondents age 65 and older (2.9%) reporting use of marijuana during the 
past year “…represented increases of 27 percent and 107 percent compared with the 
2012–2013 NSDUH; and 100 percent and 625 percent compared with the 2006–2007 
survey” (Perlman, 2019). Moreover, results from the 2015-2016 NSDUH also showed 
that rates of marijuana use were three times more prevalent in middle aged participants 
than in the older group (Han & Palamar, 2018; Perlman, 2019). The prevalence of 
marijuana use in the Middle Age cohort compared to the Old Age cohort in the present 
study, appears to be similar, but slightly less than the national averages reported in a 
similar time frame as the year the data were collected for the present study (the Middle 
Age cohort reported approximately 2.5 times more past-year marijuana use compared to 
the Old Age cohort). These findings represent a growing public health risks, especially 
given that additional analyses show strong associations between marijuana use later in 
life and higher likelihood to struggle with cocaine abuse, prescription opioid misuse, 
nicotine dependence and major depression (Perlman, 2019). Of note, older past-year 
marijuana users are at approximately 8 times greater odds of cocaine use than those who 
did not report using marijuana in the past year (Han & Palamar, 2018). Therefore, the 
high rate of past year cocaine abuse (13.1%), as well as stimulant abuse (7.3%), in the 
Middle Age cohort compared to all the other age groups, in the present study, may be 





National statistics suggest that the problem of the heroin and prescription opioid 
and benzodiazepine misuse may be growing exponentially in U.S. older populations. 
Huhn, Strain, Tompkins, and Dunn (2018) examined the rates of first-time treatment 
admissions for primary opioid use disorder in adults age 55 and older and they found that 
they almost doubled in this population since 2007, with the sharpest increase occurring 
between 2013 and 2015 (53.5%), with the large majority being heroin abusers. These 
rapid increases in the rates of opioid abuse disorder in older adults contrast the steady 
increase in younger populations, with approximately 10% more first-time treatment 
admissions per year since 2007 (Huhn et al., 2018).   
Research findings also suggest a significant link between prescription opioid and 
benzodiazepine abuse and misuse in older populations. Schepis, Simoni‐Wastila, and 
McCabe (2019) analyzed the 2015-2016 NSDUH data to examine the potential risks 
associated with prescription misuse in adults age 50 and older. They found that those 
participants who misused both prescription opioids and benzodiazepines, were 10 times 
more likely to have serious suicidal ideations then those who did not misuse these 
substances in the past year (Schepis et al., 2019). Unfortunately, little is understood about 
this special risk in older populations and more research is needed to better understand 
additional health risks associated with the co-administration and misuse of both 
benzodiazepines and opioids (Maree et al., 2016). The present study shows similar rates 
between opioid and sedative/hypnotic/anxiolytic past year abuse in the Middle Age 
Cohort, the age group that showed significantly higher rates of past year misuse of those 
substances in comparison to the age cohorts. Future research examining the health risks 





present study’s older groups may reveal meaningful insights for prescribing 
practitioners.  
Principal components analyses (PCAs) exploring factor structure within each 
distinct scale (i.e., the CUAPOS and CUDPOS), revealed a similar two-factor structure 
for both scales. The two scales share conceptually similar two factor structures, with one 
factor’s items appearing to assess cognitions associated with one’s own substance use 
(i.e., one’s self-awareness of their substance abuse problems), and the other assessing for 
behaviors associated with SUD. However, the PCA results as well as the orthogonal (i.e., 
near zero correlation) suggest that the two scales may be conceptually different. 
A series of confirmatory factor analyses (CFAs) were performed in order to 
confirm the factor structure found in PCAs for each respective scale and find the best 
fitting model for each scale across age groups. This procedure was necessary in order to 
find the best model fit for both the CUAPOS and the CUDPOS across Age 
Cohorts. CFAs on the overall sample showed good fit for the two-factor structure in each 
respective scale, across age groups. Measurement invariance testing using multi-level 
CFAs showed non-invariance in both the CUAPOS and the drug abuse problem scale, 
suggesting that there are meaningful differences in how participants responded to each 
scale based on their age cohort. This result may reflect national trends showing key 
differences between youth and older adult substance abusers (NSDUH 2018). 
A one-way ANOVA examining Age Cohort comparisons of mean scores on the 
CUAPOS showed nonsignificant differences across Age Cohorts on the CUAPOS. The 
only notable group differences found from conducting two-way ANOVAs and 





CUAPOS however no main effect was found between Race and participant scores on the 
CUAPOS.  The interaction showed that Persons of Color in the Young Adult group 
scored significantly lower on the CUAPOS than the other Age Cohort groups, including 
the Adult, Middle Age, and Older Adult groups. Results from this analysis also shows 
that the Young Adult, Person of Color, group endorsed significantly less problems on the 
CUAPOS compared to White participants in the Young Adult group. Results appears to 
be consistent with national reports indicating that alcohol abuse in youth populations has 
continued trending down since 2015. Research also supports the present study’s finding 
that young Persons of Color may be at less risk for severe alcohol use disorder compared 
to White youth. Several psychosocial factors may explain this difference in youth 
populations, including peer use, parental factors, and religiosity (Dickens , Jackman, 
Stanley, Swaim, & Chavez, 2018; Su et al., 2020). Dickens and colleagues (2018) 
compared the prevalence and effects of psychosocial risk factors for alcohol abuse 
problems between White and African American rural adolescents. They found that 
religiosity, peer use, and parental permissiveness were factors that were more strongly 
associated with increasing the risk of alcohol abuse in White youth compared to African 
American youth. Although racial discrimination has been shown to increase the risk of 
African American youth abusing alcohol and other substances, appropriate racial 
socialization by peers has been shown to be a significant protective factor from alcohol 
abuse problems in young Persons of Color (Su et al., 2020). In contrast, the Middle Age, 
Persons of Color group showed significantly higher reports of alcohol abuse problems 
than any other Age Cohort across both Race groups. Research examining differences in 





social support as risk factors that have a significantly greater impact on middle age or 
older adults in African American populations compared to Whites (Karriker-Jaffe, 
Witbrodt, & Mulia, 2019). One of the potential consequence of these low education 
attainment and poor social support, economic disadvantage, is one of the greatest risk 
factors for alcohol use disorder in Middle Age populations in African American 
communities (Assari, Smith, Mistry, Farokhnia, & Bazargan,, 2019). It is important to 
note that these results may be difficult to interpret due to unequal sample sizes in each 
group with the large majority being White (N = 548) and the Persons of Color group 
being much smaller (N = 76). In addition, this variable is limited in its ability to provide 
descriptive information on race and ethnicity, given that the sample sizes of individual 
race groups were too small (N < 50) to be examined as more descriptive race groups in 
the present analyses.  
Group Comparisons for the CUDPOS 
A one-way ANOVA examining mean differences in participants’ responses to 
items on the CUDPOS between Age Cohorts, found significant differences between the 
Young Adult group and two other Age Cohorts: Middle Age and Old Adults. This 
finding is consistent with the results from the present study’s chi-square tests, describing 
the prevalence of drug abuse problems within each Age Cohort. Moreover, results from 
both the initial ANOVA and crosstabulations (chi-square tests) comparing drug abuse 
problems showed results that are consistent with national and global trends. While both 
national and global SUD trends show a progressive decrease in abuse of alcohol and most 
illicit drugs, public health officials are concerned that certain drug abuse, especially 





youth populations, given that national and global trends indicate that they (i.e., ages 12 to 
25) are the age group most likely to perceive cannabis abuse as having low health risks, 
and therefore, they are at highest risk for engaging in cannabis abuse early in life, 
particularly before age 19 (NSDUH 2018; Lipari et al, 2017). There is evidence that 
suggests the trending increase in cannabis abuse also puts youth at risk for developing 
problems with cocaine abuse, nicotine dependence, major depression, and prescription 
opioid abuse later in life (Perlman, 2019). 
A two-way ANOVA examining the interaction effect of age and gender on 
participants’ reported drug abuse problems. Results showed a nonsignificant interaction 
effect between age and gender on drug abuse problems, similar to age, gender showed a 
main effect on drug abuse problems across Age Cohorts. Figure 1 shows significant 
differences and similarities comparing the two gender groups across the four different age 
groups (i.e., Young Adult, Adult, Middle Age, and Older Adult). The most dramatic 
differences in drug abuse problems between gender groups are shown in early adulthood 
(i.e., Young Adult and Adult age groups), with females reporting significantly less drug 
abuse problems than males, most notably in the Adult age group. In fact, the mean score 
on the CUDPOS in the male, Adult age group, was the highest compared to the other 
male age groups, whereas the female, Adult age group scored the lowest compared to the 
other female age groups, with the most dramatic decrease showing between the Young 
Adult and Adult female groups. Research suggests that the differences between male and 
female drug abuse behaviors are nuanced. A recent cross-sectional study, based on 
interview data from Swedish adolescents in outpatient clinics, found that females tend to 





difficult home environments than boys, and are more likely to have problems related to 
school, more serious substance abuse problems, and more severe mental health problems 
(Anderberg & Dahlberg, 2018). Anderberg and Dahlberg (2018) highlighted a “gender 
paradoxical relationship” in which females enter treatment for substance abuse problems 
at much lower rates than men; however, females who struggle with SUD tend to 
experience more life problems. Reports from the 2017 NSDUH data show that while 
much of the current research and public support for the opioid epidemic is aimed at 
women, there is a rapidly growing problem of opioid use disorder and prescription drug 
misuse among U.S. males (Silver & Hur, 2020).  
An ANCOVA examining the moderating effect that childhood trauma may have on the 
mean differences in CUDPOS scores between age groups, revealed that childhood trauma 
is a significant covariate that influences the significant relationship between age and drug 
abuse problems. This finding is consistent with research showing that Adverse Childhood 
Events (ACEs), significantly predict life-time substance abuse problems, starting in 
adolescence and into older adulthood (Choi, DiNitto, Marti, & Choi, 2017). While ACEs 
similarly predict SUD outcomes across demographic groups, notable differences between 
gender and racial groups who are victims of childhood trauma who struggle with SUD 
throughout adulthood. Choi and colleagues (2017) examined data (N = 14,738 for the 50 
and older age group), from the 2012 to 2013 National Epidemiologic Survey on Alcohol 
and Related Conditions. They found that boys who experience ACEs are more likely to 
develop antisocial behaviors early in young adulthood compared to girls who report 
similar ACEs, and White participants reported greater adverse mental health impact 





relationship between childhood trauma and SUDs, found significant correlations between 
levels of childhood trauma, including physical, sexual, and emotional abuse, substance 
abuse (particularly cocaine abuse), and current PTSD symptoms (Khoury et al., 2010).  In 
fact, the authors explained that while controlling for exposure to adult trauma, a 
significant additive effect of the number of different types of childhood trauma, 
combined with a history of cocaine dependence was found to be predictive of current 
PTSD symptoms (Khoury et al., 2010). Future research examining data from the MIDAS 
project may reveal additional insights regarding the relationship between childhood 







Given that substance abuse behaviors are typically under-reported, self-report 
measures may provide a limited view of the scope and severity of SUD within this 
sample (Tourangeau and Yan, 2007). This issue may be due to lack of insight regarding 
the severity of problems associated with SUD, fear of repercussions, or social 
desirability. Moreover, while the participants included in the two-way ANOVA and 
ANCOVAs examining demographic characteristics and SUD risk factors (i.e., race, sex, 
mood impairment, childhood trauma, self-injury, and ADHD) endorsed at least one 
substance abuse or dependence related problem in the past week (i.e., on the CUAPOS or 
the CUDPOS), many participants in the present sample did not respond to information on 
every measure used in the present analyses.  For example, of the total sample that 
completed the self-report questionnaires (N= 624), approximately half of these 
participants completed the ASRS (n= 326). Therefore, interpretations of the results from 
the present analyses should consider the potential for under-reporting. 
Another potential limitation of this sample is that participants were recruited from 
an outpatient mental health setting. This sample may represent a subsample of patients 
with SUD who are more willing to seek treatment and are currently experiencing less 
severity of symptoms than those in partial and inpatient mental health or residential 
rehabilitation programs. Moreover, the participants are privately insured, and research 
consistently shows a longstanding history of healthcare disparities between the insured 
and uninsured or underinsured U.S. patient populations (Angier et al., 2017). Overall, 
research suggests that uninsured patients are significantly less likely to seek healthcare 





appointments compared to insured patients. Given that poorer healthcare resources puts 
one at risk for mental health problems and SUD, it can be assumed that the results from 
the present study may vary between patient populations with different socioeconomic 
backgrounds. Therefore, the generalizability of these findings to the SUD population 
overall may be limited such that the present study’s sample may represent a more 
privileged group of treatment seeking patients.  
Lastly, a major limitation in the present study overall, is that the Chi-square 
difference tests on the two respective scales of interest (the CUAPOS and the CUDPOS) 
show non-invariance between Age Cohorts. This means that while the overall goodness 
of fit indices for the total sample (N= 577), as well as the goodness of fit indices within 
each Age Cohort showed good model fit, the manner in which participants in different 
age groups interpret and respond to items is different for each respective scale. Given that 
the nature of these age group differences in the present study’s sample is unclear, 
interpretation of results from the ANCOVA and two-way ANOVAs following the 






Suggestions for Future Research 
 It is important to note that the measurement development portion of the present 
study does not include participants who denied past year drug abuse in their SCID 
interviews, potentially eliminating useful information from participants who identify as 
recovering addicts who have stayed sober past one year, and those who have no SUD 
history. Qualitative data from the non-substance abusers in the overall MIDAS project 
sample may provide useful insights on stigma and other sociocultural issues related to 
SUD problems. The role of the patient’s primary care physician (e.g., medication 
management, SUD assessment, and SUD treatment) is another important area to explore 
in future research. Physician stigma against patients struggling with SUD has been shown 
to have a negative impact on patient empowerment and treatment outcomes (Van Boekel, 
Brouwers, Van Weeghel, & Garretsen, 2013). Therefore, in addition to better 
understanding how stigma in the general population may negatively impact SUD 
problems, the influence that physician biases about substance abuse may have on their 
patients’ assessment and treatment outcomes, may be another important area to explore in 
future research. 
Given that generalizability of the present study’s sample may be limited, due to 
factors such as insurance status (i.e., sample is limited to privately insured patients) and 
substance abuse and dependence status (i.e., sample is limited to patients with past-year 
substance), and small group sizes in some of the study’s variables (e.g., Race), replication 
of this study with a larger, more diverse sample of participants who report past-year 
substance abuse may provide different results. A larger, randomized sample would likely 





measurement development efforts to improve the CUDPOS and CUAPOS scales are 
necessary to ensure invariance of the measures by age groups.  This effort could also 
evaluate the invariance of the new scales by potentially important demographic groups 
such as gender or race. This research has the potential to provide two novel, and reliable 
screeners for alcohol and drug abuse problems that physicians can efficiently utilize in 
outpatient settings in order to improve the treatment outcomes of patients from diverse 
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Adult ADHD Self-Report Scale 
Instructions: 
Please answer the questions below, rating yourself on each of 
the criteria shown using the scale on the right side of the page. 
As you answer each question, place an X in the box that best 
describes how you have felt and conducted yourself over the 

























1. How often do you have trouble wrapping up the final 
details of a project once the challenging parts have been 
done? 
 
     
2. How often do you have difficulty getting things in order 
when you have to do a task that requires organization? 
 
     
3. How often do you have problems remembering 
appointments or obligations? 
 
     
4. When you have a task that requires a lot of thought, how 
often do you avoid or delay getting started? 
 
     
5. How often do you fidget or squirm with your hands or feet 
when you have to sit down for a long time? 
 
     
6. How often do you feel overly active and compelled to do 
things, like you were driven by a motor? 
 
     
7. How often do you make careless mistakes when you have 
to work on a boring or difficult project? 
 
     
8. How often do you have difficulty keeping your attention 
when you are doing boring or repetitive work? 
 
     
9. How often do you have difficulty concentrating on what 
people say to you, even when they are speaking to you 
directly? 
 
     
10. How often do you misplace or have difficulty finding 
things at home or at work? 
 
     
11. How often are you distracted by activity or noise around 
you? 
 






Please answer the questions below, rating yourself on each of 
the criteria shown using the scale on the right side of the page. 
As you answer each question, place an X in the box that best 
describes how you have felt and conducted yourself over the 
























12.  How often do you leave your seat in meetings or other 
situations in which you are expected to remain seated? 
 
     
13.  How often do you feel restless or fidgety? 
 
     
14.  How often do you have difficulty unwinding and relaxing 
when you have time to yourself? 
 
     
15.  How often do you find yourself talking too much when 
you are in social situations? 
 
     
16.  When you're in a conversation, how often do you find 
yourself finishing the sentences of the people you are 
talking to, before they can finish them themselves? 
 
     
17.  How often do you have difficulty waiting your turn in 
situations when turn taking is required? 
 
     
18.  How often do you interrupt others when they are busy? 
 
     
  






Childhood Trauma Questionnaire 
Instructions: These questions ask about some of your experiences growing 
up as a child and a teenager. For each question, circle the number that best 
describes how you feel. Although some of these questions are of a personal 














1. There was someone in my family 
whom I could talk to about my 
problems. 
 
     
2. People in my family criticized me.      
3. I didn't have enough to eat.      
4. People in my family showed 
confidence in me and encouraged 
me to succeed. 
     
5. Someone in my family hit me or 
beat me. 
     
6. I lived in a group or foster home.      
7. I knew that there was someone to 
take care of me and protect me. 
     
8. Someone in my family yelled and 
screamed at me. 
     
9. I saw my mother or one of my 
brothers or sisters get hit or 
beaten. 
     
10. People in my family called me 
things like "stupid," "lazy," or 
"ugly." 
 
















11. I was living in the streets by the 
time I was a teenager or even 
younger. 
     
12. There was someone in my family 
whom I admired and wanted to be 
like. 
     
13. My parents were too drunk or high 
to take care of the family. 
     
14. People in my family got into 
trouble with the police. 
     
15. There was someone in my family 
who helped me feel that I was 
important or special. 
     
16. I had to protect myself from 
someone in my family by fighting, 
hiding, or running away. 
     
17. There was someone in my family 
who wanted me to be a success. 
     
18. I had to wear dirty clothes.      
19. I lived with different people at 
different times (like different 
relatives or foster families). 
     
20. I believe that one of my brothers or 
sisters might have been molested. 
     
21. I felt loved.      
22. My parents tried to treat all of 
children the same. 
     
23. I thought that my parents wished I 
had never been born. 
     
24. I got hit so hard by someone in my 
family that I had to see a doctor or 
go to the hospital. 
















25. There was someone in my family 
who made sure that I stayed out of 
trouble. 
     
26. People in my family hit me so hard 
that it left me with bruises or marks. 
     
27. I had sex with an adult or with 
someone who was a lot older than 
me (someone at least 5 years older 
than me). 
     
28. There was someone older than 
myself (like a teacher or a parent) 
who was a positive role model. 
     
29. I was punished with a belt, a board, 
a cord, or some other hard object. 
     
30. There was nothing I wanted to 
change about my family. 
     
31. People in my family looked out for 
each other. 
     
32. People in my family said hurtful or 
insulting things to me. 
     
33. I believe that I was physically 
abused. 
     
34. People in my family tried to keep 
me away from bad influences. 
     
35. I got hit or beaten so badly that I 
was noticed by someone like a 
teacher, neighbor, or doctor. 
     
36. People in my family seemed out of 
control. 
     
37. People in my family encouraged me 
to stay in school and get an 
education. 
     
38. I spent time out of the house, and 
no one knew where I was. 

















39. The punishments I received seemed 
cruel. 
     
40. Someone in my family hated me.      
41. People in my family felt close to 
each other. 
     
42. Someone tried to touch me in a 
sexual way or tried to make me 
touch them. 
     
43. People in my family pushed me or 
shoved me. 
     
44. Someone threatened to hurt me or 
tell lies unless I did something 
sexual with them. 
     
45. I had the perfect childhood.      
46. I was frightened of being hurt by 
someone in my family. 
     
47. Someone tried to make me do 
sexual things or watch sexual 
things. 
     
48. Someone in my family believed in 
me. 
     
49. Someone molested me.      
50. I believe that I was emotionally 
abused. 
     
51. I believe that I was emotionally 
abused. 
     
52. I believe that I was sexually abused.      
53. My family was a source of strength 
and support. 
     
 
         (Bernstein, Fink, Handelsman, & Foote, 1994)  







In the past 3 months, have you done any of the following to deliberately 
hurt yourself? 
 
1. Cut yourself with a sharp object  
0 1 2 3 
2. Scratched yourself? 
0 1 2 3 
3. Hit yourself?  
0 1 2 3 
4. Burned yourself? 0 1 2 3 
5. Picked areas of your body to the point of 
drawing blood? 0 1 2 3 
6. Banged your head, arms, or legs to the point of 
bruising? 
0 1 2 3 
7. Pulled out your hair? 
0 1 2 3 
8. Chewed the inside of your mouth to the point of 
bleeding? 
0 1 2 3 
9. Hurt yourself while masturbating? 0 1 2 3 
10. Cut, burned, or scratched your genitals? 0 1 2 3 
11. Picked at wounds? 
0 1 2 3 
12. Carved words on your skin? 
0 1 2 3 
13. Other damage to your body? 






Table 1.  
 
 Crosstabulations Comparing Past-year Drug Abuse and Dependence by Drug Type Across Four Age Cohorts in A Sample Of 
1,620 Psychiatric Outpatients 
 





Cannabis Stimulants Opioids      Cocaine     Hallucinogens 
Ages  
Past-year Abuse 
(Yes/No) n % n % n % n % n % n % 
18-25 Yes 41a 3.0 344a 21.2 32a 2.0 60a 3.7 75a 4.6 51a 3.1 
No 322a 19.9 19a 1.2 331a 20.4 303a 18.7 288a 17.8 312a 19.3 
26-35 Yes 39a 2.4 380b 23.5 43a 2.7 65a 4 147b, c 9.1 70a 4.3 
No 394a 24.3 53b 3.3 390a 24.1 368a 22.7 286b, c 17.7 363a 22.4 
36-49 
Yes 105b 6.5 492b 30.4 119b 7.3 99a 6.1 212c 13.1 85a 5.2 
No 477b 29.4 90b 5.6 463b 28.6 483a 29.8 370c 22.8 497a 30.7 
50 + 
Yes 38a, b 2.3 218a, b 13.5 45b 2.8 35a 2.2 60a, b 3.7 27a 1.7 
No 204a, b 12.6 24a, b 1.5 197b 12.2 207a 12.8 182a, b 11.2 215a 13.3 
χ2 (p-value) < .001** < .001**     < .001**   .74 < .001** .36 
 
Notes. Chi-square analyses were used to compare past year drug abuse between Age Cohorts, within each drug type. Each subscript 
letter denotes a subset of Age Cohorts categories whose column proportions do not differ significantly from each other (p > .05). 
 








Descriptive Characteristics Including Gender and Race by Age Cohort in a Sample With Past-
year Substance Abuse and Dependence (N = 727) 
 
Demographic 
Characteristics Age Cohort 
 Young Adult Adult Middle Age Old Adult Full Sample 
 n % n % n % n % n % 
Gender           
Female 98 13.5 83 11.4 128 17.6 76 10.5 385 53.0 
Male 83 11.4 64 8.8 111 15.3 84 11.6 342 47.0 
Race           
White 157 21.6 127 17.5 209 28.7 147 20.2 640 88.0 
Black 11 1.5 7 1.0 11 1.5 6 0.8 35 4.80 
Hispanic 6 0.8 5 0.7 5 0.7 1 0.1 17 2.30 
Asian 4 0.6 5 0.7 1 0.1 1 0.0 10 1.40 
Portuguese 2 0.3 2 0.3 6 0.8 6 0.8 16 2.20 
Other 1 0.1 1 0.1 7 1.0 0 0.0 9 1.20 
Total  181 24.9 147 20.2 239 32.9 160 22.0 727 100 
 
Note. This sample was split for confirmatory factor analyses (N= 577) and principal 







   
Descriptive Characteristics Including Gender, and Race, By Age Cohort in The 
Subsample Used for Principal Components Analyses (N = 150)   
Descriptive 
Characteristic Age Cohort 
 Young Adult Adult 
Middle 
Age Old Adult Full Sample 
 n % n % n % n % n % 
Gender           
Female 16 10.7 20 13.3 30 20.0 19 12.7 85 56.7 
Male 14 9.3 11 7.3 23 15.3 17 11.3 65 43.3 
Race           
White 27 18.0 25 16.7 49 32.7 35 23.3 136 90.7 
Person of 






Exploratory Factor Structure of the Initial 30 Items in the CUSAPOS (N= 150) 
 
Scale Items Factor Loadings 







63. I was intoxicated from alcohol. 1.03 1.187 .712 - 
64. I drink alcohol more than I should.  .99 1.253 .855 - 
65. Others complained about my drinking. .45 .959 .656 - 
66. I thought my drinking was a problem. .68 1.076 .786 - 
67. I had more than three drinks of alcohol in a day. .99 1.232 .769 - 
68. I thought about cutting down or stopping 
drinking. 1.05 1.375 .768 
- 
69. I tried to limit the amount of drinking I did. 1.15 1.407 .676 - 
70. I tried to cut down or stop drinking. .99 1.318 .682 - 
71. I couldn’t stop drinking when I wanted to. .47 .995 .827 - 
72. I had a strong urge to drink alcohol. .92 1.256 .610 - 
73. I drove after having two or more drinks of 
alcohol.  .57 1.089 .667 
- 
74. I was hung over from drinking alcohol .58 1.070 .624 - 
75. I drink alcohol during the morning.  .19 .642 .574 - 
76. I drank alcohol even though it caused problems 
in my life. .41 .928 .777 
- 
77. I felt guilty about my drinking of alcohol.  .56 1.096 .757 - 
78. I was high on drugs.  .57 1.149 - .791 
79. I used street drugs. .46 1.066 - .723 
80. I used drugs more than I should. .45 1.114 - .913 







Scale Items    Factor Loadings 







82. others complained about my drug use.  .37 1.019 - .813 
83. I thought about cutting down or stopping my 
drug use.  .57 1.239 
- .938 
84. I tried to limit the amount of drugs I use. .51 1.191 - .855 
85. I tried to cut down or stop my drug use.  .48 1.168 - .834 
86. I couldn't stop using drugs when I wanted to.  .31 .919 - .803 
87. I had a strong urge to use drugs. .50 1.145 - .816 
88. I drove after using drugs. .43 1.039 - .772 
89. I felt depressed after or paranoid after using 
drugs.  .29 .892 
- .617 
90. I use drugs in the morning.  .35 .997 - .643 
91. I use drugs even though it caused problems in 
my life.  .34 .954 
- .835 
92.I felt guilty about my drug use. .49 1.169 - .898 
 
Note. Principal components analysis, with a promax (oblique) rotation, was the statistical 
method used to explore the factor structure of the total 30 items in the proposed CUSAPOS 
measure.  
 
M= mean; SD = standard deviation.   











 M SD Factor 1: Insighta 
Factor 2: 
Behaviorsb 
CUAPOS     
 
64. I drink alcohol more than I should.  
 
.99 1.25 .758 .144 
65. Others complained about my drinking. 
 .45 .96 .801 -.046 
66. I thought my drinking was a problem. 
 .68 1.08 .077 .827 
67. I had more than three drinks of alcohol in a 
day. 
 
.99 1.23 .811 -.008 
70. I tried to cut down or stop drinking. 
 .99 1.32 -.169 .905 
73. I drove after having two or more drinks of 
alcohol.  
 
.57 1.09 .928 -.190 
75. I drink alcohol during the morning.   .19 .64 .490 .226 
76. I drank alcohol even though it caused 
problems in my life. 
 
.41 .93 .574 .316 
77. I felt guilty about my drinking of alcohol.   .56 1.0 .070 .807 
CUDPOS 
78. I was high on drugs.  .57 1.15 .340 .542 
81. I thought that my drug use was a problem.  .35 .97 .800 .140 
82. others complained about my drug use.  .37 1.02 .937 -.092 
85. I tried to cut down or stop my drug use.  .48 1.17 .637 .270 
86. I couldn't stop using drugs when I wanted to.  
 .31 .92 .768 .130 









 M SD Factor 1: Insighta 
Factor 2: 
Behaviorsb 
CUDPOS     
 
89. I felt depressed after or paranoid after using 
drugs  
.29 .892 -.297 1.085 
 
90. I use drugs in the morning  
 
.35 .997 .916 -.269 
91. I use drugs even though it caused problems in 
my life  
 
.34 .954 .405 .570 
 
Notes. Factor loadings that were confirmed with confirmatory factor analyses. Each scale 
shows a two-factor structure, and the number in bold indicates which factor that item 
loading appears to represent. Log transformation was used to correct normality of the 
distribution of scores across Age Cohorts. 
 
M = mean score; SD = standard deviation 
 
a. Items reflect one’s insight or self-awareness of substance abuse problems  
 











Goodness of Model Fit for the CUAPOS and CUDPOS by Age Cohort 
CUAPOS 
Age Cohort Goodness-of-fit Indices 




Young Adult  152 26 0.996 0.994 0.070 0.073 0.011 
Adult 132 26 .999 0.998 0.051 0.080 0.144 
Middle Age 201 26 1.0 1.0 0.014 0.044 0.410 
Older Adult 139 26 1.0 1.0 0.016 0.074 0.417 
Full Sample 624 36 0.997 0.995 0.064 0.046 > .001 
CUDPOS 
Age Cohort Goodness-of-fit Indices 
 
 N DF CFI TLI RMSEA SRMR 
χ2 
(p value) 
Young Adult  152 19 1.0 1.0 0.0 0.043 0.58 
Adult 132 19 1.0 1.0 0.0 0.033 0.868 
Middle Age 201 19 1.0 1.0 0.0 0.026 0.981 
Older Adult  139 19 1.0 1.0 0.0 0.070 0.722 
Full Sample 624 28 0.972 0.958 0.081 0.031 > .001 
 
Note. Confirmatory factor analyses showed good model fit across Age Cohorts for 
both scales. 
 
N = number of participants; DF = degrees of freedom; CFI = comparative fit index; 
TLI = Tucker–Lewis index; RMSEA = root mean error of approximation; SRMR = 
standardized root mean square residual 
 







Multigroup Confirmatory Factor Analyses for the CUAPOS and CUDPOS 
CUAPOS 








0.914 0.881 0.128 0.054 -- -- -- 


















0.913 0.872 0.153 0.050 -- -- -- 





(94)      
0.900 0.881 0.148 0.094 M1 57.36 
(18)       
Reject 
 
Note. Invariance test results show non-invariance in participant responses to items on both 
the CUAPOS and the CUDPOS, across Age Cohorts. 
 
 Δχ2 (Δdf) = Chi-square difference between M1 and M2 (degrees of freedom);  
CFI = comparative fit index; TLI = Tucker–Lewis index; RMSEA = root mean error of 









Descriptive Statistics and Correlations of the Study Scales  
Scale n M SD 1  2 3 4 5 
1. CUAPOS 624 6.63 7.4 -     
2. CUDPOS 624 3.24 6.15 0.02 -    
3. Adult ADHD Self-Report 
Scale (ASRS) 326 35.39 12.67 0.02 .15** -   
4. Self-Injury Questionnaire 
(SIQ) 515 2.04 3.56 0.04 .09* .26** -  
5. Childhood Trauma 
Questionnaire (CTQ) 544 106.78 45.88 0.01 -.09* 0.07 0.07  - 
 
Notes. Table 8 shows significant correlations between scores on the CUDPOS 
and three other scales: ASRS, SIQ, and CTQ. The ASRS and SIQ also show a 
significant relationship. 
n= total number of participants who completed the respective scale; SD= 
standard deviation; M= mean scores 
** Correlation is significant at the p < .01 level 



























Descriptive Characteristics for Gender, Race, and Mood Impairment by Age Cohort in a Sample Who 
Reported Substance Abuse Problems in the Past Week (N= 624) 
 
Descriptive 
Characteristic Age Cohort 
 Young Adult Adult Middle Age Old Adult Full Sample 
 n % n % n % n % n % 
Gender           
Female 80 12.8 71 11.4 104 16.7 67 10.7 322 51.6 
Male 72 11.5 61 9.8 97 15.5 72 11.5 302 48.4 
Race           
White 133 21.3 113 18.1 175 28.0 127 20.4 548 87.8 
Person of Color 19 3.0 19 3.0 26 4.2 12 1.9 76 4.8 
Impairment/ 
Distress 
          
No 91 14.6 57 9.1 100 16.0 66 10.6 314 50.3 
Yes 61 9.8 75 12.0 101 16.2 73 11.7 310 49.7 
Total Sample 152 24.4 132 21.2 201 32.2 139 22.3 624 100 
 
Notes. Crosstabulations describe the variables Race, Gender, and Mood Impairment by Age Cohort in a 
subsample who reported experiencing at least one alcohol or drug problem in the past-week. This 
subsample was used for analyses comparing mean scores on the CUDPOS and CUAPOS by Age Cohort, 







Notes. ANOVA results comparing mean scores on the CUAPOS and CUDPOS, show 
significant differences in self-reported drug abuse problems between the Young Adult 
and the Middle Age and Older Adult groups. No significant differences were found 
between Age Cohorts in alcohol abuse problems. 
ns= non-significant; M= mean score; sd= standard deviation 
 
  

















 M (sd) M (sd) M (sd) M (sd)   
CUAPOS 1.54 (.97) 1.52 (1.04) 1.62 (.96) 
1.59 
(1.02) 
F (3, 620) = 
.368, p = .776 ns 





Table 11.  
Two-way ANOVA on CUDPOS Scores by Age Cohort by Gender  
Predictor Sum of Squares df Mean Square F p Partial η
2 
Intercept 341.92 1 341.92 308.03 .000 .333 
Age Cohort 13.41 3 4.47 4.03 .007** .019 
Gender 8.35 1 8.35 7.53 .006** .012 
Age Cohort x 
Gender 
8.29 3 2.76 2.49 .059 .012 
Error 683.78 616 1.11    
 
Note. Two-way ANOVA results show a main effect between age and drug abuse 
problems, and gender and drug abuse problems. 
 









b. Childhood Trauma Questionnaire (CTQ) scores were log transformed 
 
* Statistical significance at the p < .01 level 
 
  
ANCOVA on CUDPOS scores by Age Cohort While Controlling for Childhood Trauma  




F p Partial η2 
Corrected Model 11.980a 4 2.995 2.609 .035* .019 
Intercept 62.326 1 62.326 54.304 .000 .092 
CTQb 1.358 1 1.358 1.183 .277 .002 
Age Cohort 9.806 3 3.269 2.848 .037* .016 
Error 618.625 539 1.148    
 
 
Note. ANCOVA results suggest that childhood trauma is a covariate that significantly 
influences the relationship between CUDPOS and Age.  
 






Figure 1.  
 
 
Figure 1. A two-way ANOVA showing a significant interaction effect between Age 
Cohort and Race on mean scores on the CUAPOS. Scores were log transformed to meet 
statistical assumptions for ANOVA. 
 
